Depending on the location and type of pathogenic variant per se, CRB1 mutations may differentially affect CRB1-A and CRB1-B, thereby contributing to phenotypic severity and determining whether patients develop non-congenital macular dystrophy or LCA. The gene discussed is CRB1; the disease is Leber congenital amaurosis.